Slate Bio logo

Slate Bio Funding & Investors

Charlottesville, VA

Slate Bio is an immunotherapeutics development company that develops therapies that restore the body's natural immunological response in different diseases using bifunctional IL233 cytokine, thereby providing users with an independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics.

slatebio.com

Total Amount Raised: $4,526,949

Slate Bio Funding Rounds

  • Series Unknown

    $2,776,949

  • Seed

    $1,750,000

    Seed Investors

    Epidarex Capital
    VTC Seed Fund
    Uva Licensing & Ventures Group
    Virginia Venture Partners
    Pharma Directions
Funding info provided by Diffbot.